Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

June 24, 2020

Study Completion Date

June 24, 2020

Conditions
Borderline Personality Disorder
Interventions
DEVICE

MagPro MST with Cool TwinCoil

MST treatments will be administered using the MagPro MST with Cool TwinCoil. The investigators will evaluate the effectiveness of MST for reducing suicidality and depressive symptoms in an open-label clinical trial of up to 15 treatment sessions. Moderate-to-highly suicidal patients with BPD beginning dialectical behavioural therapy (DBT) will be recruited using a case-control design, comparing individuals receiving MST and DBT with matched patient control group receiving DBT alone.

BEHAVIORAL

DBT

Dialectical behavior therapy (DBT) is a specific type of cognitive-behavioral psychotherapy developed to help better treat borderline personality disorder. Moderate-to-highly suicidal patients with BPD beginning dialectical behavioural therapy (DBT) will be recruited using a case-control design, comparing individuals receiving MST and DBT with matched patient control group receiving DBT alone.

Trial Locations (1)

M5T 1R8

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT03361826 - Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder | Biotech Hunter | Biotech Hunter